Clin2
NCT06240403Possibly a fitNot yet recruiting

Digoxin for heart failure and diabetes

Heart Failure, SystolicDiabetes Mellitus, Type 2

Treatments studied

Part of Heart & circulation, Hormones & metabolism clinical trials.

This trial tests whether a drug called digoxin can help slow down aging-related cell changes in people with both heart failure and type 2 diabetes. If you qualify, you may receive a treatment that could improve your heart health.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
100 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have heart failure with a reduced pumping strength (ejection fraction below 40%).
  • You have type 2 diabetes, and you take medication for it.
  • You are on the best possible medications for your heart failure.
  • Your kidney function is good (eGFR above 30).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06774014Recruiting
Heart failure and diabetes: cell study

This study looks at how cells talk to each other in people who have both diabetes and heart failure. It may help doctors understand these conditions better.

Leeds, West Yorkshire
NCT03878706Recruiting
Testing diabetes medicines on heart risk and heart failure

This trial studies how diabetes medicines (GLP-1 and SGLT2, alone or together) affect the heart in people with type 2 diabetes who are at higher cardiovascular risk and have heart failure with preserved pumping function. It may help find safer or more effective ways to reduce heart problems.

Athens, Attica
NCT04583800Recruiting
Tracking heart failure risk and memory change in diabetes

This study follows adults with type 2 diabetes to see who may develop heart problems and who may have memory or thinking changes over time. It may help doctors better predict risk and plan earlier support.

Lille
NCT02817360Recruiting· Phase 4
Preventing heart events in people with type 2 diabetes

This trial tests a heart-focused prevention approach to lower the risk of cardiac (heart) events in adults with type 2 diabetes. It may help by targeting early stress on the heart measured with a specific blood test.

Mödling, Lower Austria
NCT07770737Not yet recruiting
Heart protection with diabetes medicines

This study looks at whether certain diabetes medicines, called SGLT2 inhibitors and GLP-1 receptor agonists, can help protect the heart in people with type 2 diabetes. It may help you understand if these treatments are a good option for your heart health.

Hwaseong-si, Gyeonggi-do
NCT07321509Recruiting· Phase 4
Digoxin after a recent heart failure hospitalization

This trial tests whether digoxin, a heart medication, can help people who were recently hospitalized for heart failure with a weak heart pump. It aims to see if it improves symptoms and daily activity.

Buenos Aires, Buenos Aires F.D.

Hear when a new Heart Failure, Systolic trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.